The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye

The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye

John A Hovanesian,1 Andrew Keyser,1 Gregg Berdy,2 Robert Sorensen3 1Harvard Eye Associates, Laguna Hills, CA, USA; 2Ophthalmology Associates, St. Louis, MO, USA; 3Inland Eye Specialists, Hemet, CA, USACorrespondence: John A Hovanesian, Harvard Eye Associates, 23961 Calle Magdalena, Suite 300, Laguna...

Full description

Bibliographic Details
Main Authors: Hovanesian JA, Keyser A, Berdy G, Sorensen R
Format: Article
Language:English
Published: Dove Medical Press 2022-11-01
Series:Clinical Ophthalmology
Subjects:
drug delivery
dry eye
steroid
otx-ded
intracanalicular insert
dextenza
Online Access:https://www.dovepress.com/the-depot-study-dry-eye-prescription-options-for-therapy-assessing-the-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/the-depot-study-dry-eye-prescription-options-for-therapy-assessing-the-peer-reviewed-fulltext-article-OPTH

Similar Items